Targeting EpCAM (CD326) for immunotherapy in hepatoblastoma

Hepatoblastoma (HB) is the most common liver cancer in children. Recurrence of HB after chemotherapy and surgery is frequent among high-risk patients and is associated with chemoresistance. Immunotherapy may improve poor treatment outcomes in HB patients. Cytotoxic leukocytes of the innate and adapt...

Descripción completa

Detalles Bibliográficos
Autores principales: Armeanu-Ebinger, Sorin, Hoh, Alexander, Wenz, Julia, Fuchs, Joerg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583930/
https://www.ncbi.nlm.nih.gov/pubmed/23482411
http://dx.doi.org/10.4161/onci.22620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583930/
https://www.ncbi.nlm.nih.gov/pubmed/23482411
http://dx.doi.org/10.4161/onci.22620

Ejemplares similares